Save 25% wITH TAKE25 at checkout.

Join the Defiants

Sign up to be the first to know about special offers and exciting Signos news.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
April 4, 2023
|
|
3 min read
|
Written By

Signos gives every body a voice in weight loss

Real-time glucose tracking + AI-powered health recommendations deliver lasting results

NOT FOR RELEASE - Signos is on a mission to tackle the obesity epidemic through healthy habits, glucose level stabilization, and AI. Using a continuous glucose monitor and an app, Signos is powering data-driven weight loss by translating an individual’s metabolic signals into timely recommendations for eating, exercise, and better health. With over 75% of the American population overweight or obese, Signos provides a new way for people to act on their body’s unique response to what they eat. 

The Signos platform will help develop personalized answers to basic questions like what to eat, when to eat, and what exercises help encourage weight loss for each member. Signos combines a wearable continuous glucose monitor (CGM) with an AI-enhanced app to offer revolutionary real-time data and recommendations designed to drive healthy and sustained weight loss. As members begin their Signos journey, they log what they eat, allowing the Signos platform to learn each body’s reaction to specific foods. Once calibrated, Signos uses that data to provide personalized nutrition suggestions, including which foods are best for each member, when to eat them and when to exercise to bring glucose levels back within their optimal weight loss range. 

“We provide visibility into every body’s unique metabolic needs. Before, we were stuck with calorie reduction or counting macros or removing carbs altogether; now, we can work with people to turn diets that don’t work into plans that do,” said Sharam Foulagdar-Mercer, Signos’ CEO. “We help them discover this in a matter of days or weeks and refine it over time for best weight management and overall health. Elite athletes or conscientious dieters often take an extraordinary amount of trial and error to come to the same conclusion we are able to deliver in a fraction of the time.” 

Ultimately, Signos hopes to eliminate stigmas around weight loss by bringing visibility to the variation in people’s response to different meal plans. Bill Tancer, Signos Chief Data Officer, speaks from his own experience in saying, “How your body responds to eating oatmeal, a banana or a croissant and how my body responds to the exact same food is likely to be completely different. And, how our glucose spikes when we don’t sleep well, or when we’re stressed, will change our response from day to day. The most efficient path to eating well for weight loss on any given day is to check your glucose levels and make informed decisions based on that data -- and this is exactly what we’re doing. It’s changed the way I eat and the way I think about food, energy, and health.”  

Signos is now opening up its platform to a limited number of customers. To find out how your body responds to what you eat and kickstart weight loss, and secure your spot, visit www.signos.com

About Signos

Signos was launched in 2018 with a mission to tackle the obesity epidemic via healthy habits, glucose level stabilization, and AI. Signos combines continuous glucose information with an AI-enhanced app to offer revolutionary continuous data and recommendations designed to drive healthy and sustained weight loss. With over 75% of the American population overweight orobese, Signos provides a new way for people to act on their body’s unique response to what they eat to lose weight and kickstart a healthier life. Signos was started by Sharam Fouladgar-Mercer, Bill Tancer, William Dixon, and Pierre Wehbe - a team that brings deep expertise in applying data and AI to build engaging experiences with technology that changes lives for the better. Signos has raised $4M in seed funding to date. Follow us on social media @signoshealth or visit www.signos.com.

Topics discussed in this article:

No items found.

References

Table Of Contents
Hands chopping zucchini and tomatoes on a colorful cutting board

Your body runs on glucose. Harness it with Signos.

As seen in:

SIGNOS INDICATIONS: The Signos Glucose Monitoring System is an over-the-counter (OTC) mobile device application that receives data from an integrated Continuous Glucose Monitor (iCGM) sensor and is intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Signos Glucose Monitoring System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Signos Glucose Monitoring System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursions. This information may be useful in helping users to maintain a healthy weight.The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.See user guide for important warnings and precautions.
STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (Low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.
STELO INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.